Format

Send to

Choose Destination
J Nucl Cardiol. 2010 Apr;17(2):292-7. doi: 10.1007/s12350-010-9201-y.

Viability assessment with MRI is superior to FDG-PET for viability: Pro.

Author information

1
Department of Molecular and Medical Pharmacology, Division of Nuclear Medicine, David Geffen School of Medicine at University of California at Los Angeles, Los Angeles, CA, 90095-7064, USA. jmaddahi@mednet.ucla.edu
PMID:
20225004
DOI:
10.1007/s12350-010-9201-y
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center